The Alabama Medicaid Agency has issued a proposed rule that would amend regulations under AAC 560-X-16 to remove provisions that require the clinical pharmacist committee to consist of at least a long-term care pharmacist and an independent pharmacist. The rule also would allow correspondence to be directed to Medicaid’s authorized representative. Comments to the proposed rule are due October 5, 2020.
Also in Alabama, that Medicaid Agency has issued a proposed rule that would amend regulations under AAC 560-X-16 to change the current default pharmacy ingredient cost reimbursement methodology when no average acquisition cost is available from wholesale acquisition cost (WAC) +0% to WAC -4% for brand drugs and WAC +0% for generic drugs, effective January 1, 2021. Comments to the proposed rule are due October 5, 2020.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.